Discontinued — last reported Q1 '21
Operating Expenses
Impairment Charges
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ2 2016
Last reportedQ1 2021
How to read this metric
Frequent or large impairment charges signal poor capital allocation or overly optimistic historical valuations of assets.
Detailed definition
Impairment charges represent the write-down of the carrying value of assets when their fair value falls below their book...
Peer comparison
Common in cyclical industries where asset values are highly sensitive to external market price assumptions.
Metric ID:
is_impairment_chargesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $2.70B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.00M | $2.43B | $0.00 | $1.75B | $0.00 | $0.00 | $190.00M | $0.00 | $400.00M |
| QoQ Change | — | — | — | — | -100.0% | — | — | — | — | — | — | >999% | -100.0% | — | -100.0% | — | — | -100.0% | — |
| YoY Change | — | — | — | — | — | — | — | -100.0% | — | — | — | — | — | — | -100.0% | -100.0% | — | -100.0% | — |
Range$0.00 – $2.70B
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Impairment Charges at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's impairment charges?
- Gilead Sciences (GILD) reported impairment charges of $400.00M in Q4 2025.
- What does impairment charges mean?
- A reduction in the recorded value of an asset because it is worth less than its book value.